Patent Constraints Persist

Apple’s prior blood-oxygen patent dispute shows that advanced health sensors can carry meaningful legal risk. A new health tracker could require licensing, sensor redesigns, or narrower features if it touches disputed pulse-oximetry or biometric-monitoring patents.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.